Opening book details…
About this nonfiction
FDA's generic drug approval process (part 1) : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session : May 3, 10, and 11, 1989. by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
- Publisher
- U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1989.
- Published
- 1989
- Language
- EN
- Category
- nonfiction
More by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.
Similar books
- FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives ; One Hundred Second Congress, first session ; March 7 and June 5, 1991 — United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (1992)
- New Drug Approval Process — edited by Richard A. Guarino (1993)
- FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and… — United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. (2005)
- New Drugs : an Insider's Guide to the FDA's New Drug Approval Process, for Scientists, Investors, and Patients — Lawrence T. Friedhoff, Lawrence Tim (2009)
- FDA's Drug and Device Review Process : Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, Second Session, February 6, 1992. — United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (1992)
- FDA's Generic Drug Application Policy : Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, Second Session, July 28, 1988. — United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (1989)